In a rat model of PAH induced by MCT, administration of P2X7 receptor antagonist A74003 for 2 weeks reversed pulmonary vascular remodeling and significantly reduced NLRP3 inflammasome, TNF-α, and IL-1β levels (Yin et al., 2017b). Here, P2RX7 is linked to pulmonary arterial hypertension.